WO1998003218A1 - Catheter a ballonnet a coefficient d'elasticite et de resistance eleves utilisables dans le cadre du traitement de lesions gastro-intestinales - Google Patents
Catheter a ballonnet a coefficient d'elasticite et de resistance eleves utilisables dans le cadre du traitement de lesions gastro-intestinales Download PDFInfo
- Publication number
- WO1998003218A1 WO1998003218A1 PCT/US1997/012074 US9712074W WO9803218A1 WO 1998003218 A1 WO1998003218 A1 WO 1998003218A1 US 9712074 W US9712074 W US 9712074W WO 9803218 A1 WO9803218 A1 WO 9803218A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- balloon
- diameter
- atmospheres
- range
- pressure
- Prior art date
Links
- 231100001014 gastrointestinal tract lesion Toxicity 0.000 title claims abstract description 4
- 238000011282 treatment Methods 0.000 title claims description 9
- 238000000034 method Methods 0.000 claims abstract description 42
- 229920001400 block copolymer Polymers 0.000 claims abstract description 27
- 229920001169 thermoplastic Polymers 0.000 claims abstract description 17
- 238000000137 annealing Methods 0.000 claims abstract description 14
- 239000002861 polymer material Substances 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 12
- 229920000570 polyether Polymers 0.000 claims description 32
- 239000004952 Polyamide Substances 0.000 claims description 30
- 229920002647 polyamide Polymers 0.000 claims description 30
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 28
- 229920000728 polyester Polymers 0.000 claims description 18
- 230000003902 lesion Effects 0.000 claims description 16
- 238000007664 blowing Methods 0.000 claims description 15
- 150000002009 diols Chemical class 0.000 claims description 5
- 229920002635 polyurethane Polymers 0.000 claims description 5
- 239000004814 polyurethane Substances 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 229920001519 homopolymer Polymers 0.000 claims description 3
- 229920001470 polyketone Polymers 0.000 claims description 3
- 229920002959 polymer blend Polymers 0.000 claims description 3
- 229920001021 polysulfide Polymers 0.000 claims description 3
- 239000005077 polysulfide Substances 0.000 claims description 3
- 150000008117 polysulfides Polymers 0.000 claims description 3
- 229920005604 random copolymer Polymers 0.000 claims description 3
- 229920002725 thermoplastic elastomer Polymers 0.000 claims description 3
- 150000001735 carboxylic acids Chemical class 0.000 claims description 2
- 150000004985 diamines Chemical class 0.000 claims description 2
- 230000009172 bursting Effects 0.000 claims 8
- 229920001577 copolymer Polymers 0.000 claims 2
- 229920000642 polymer Polymers 0.000 description 15
- 208000031481 Pathologic Constriction Diseases 0.000 description 11
- 229920002614 Polyether block amide Polymers 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- -1 polyethylene Polymers 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000002399 angioplasty Methods 0.000 description 5
- 230000010339 dilation Effects 0.000 description 5
- 210000000111 lower esophageal sphincter Anatomy 0.000 description 5
- 208000000289 Esophageal Achalasia Diseases 0.000 description 4
- 206010030136 Oesophageal achalasia Diseases 0.000 description 4
- 201000000621 achalasia Diseases 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 239000000806 elastomer Substances 0.000 description 4
- 210000003238 esophagus Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 229920011372 Arnitel® EM740 Polymers 0.000 description 2
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 2
- 229920000299 Nylon 12 Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004734 Polyphenylene sulfide Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000000414 obstructive effect Effects 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 229920000069 polyphenylene sulfide Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- IUGOPULVANEDRX-UHFFFAOYSA-N 2-ethylhexane-1,1-diol Chemical compound CCCCC(CC)C(O)O IUGOPULVANEDRX-UHFFFAOYSA-N 0.000 description 1
- 239000004953 Aliphatic polyamide Substances 0.000 description 1
- 206010057202 Biliary dilatation Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 208000007217 Esophageal Stenosis Diseases 0.000 description 1
- RYECOJGRJDOGPP-UHFFFAOYSA-N Ethylurea Chemical compound CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010074061 Large intestinal stenosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030164 Oesophageal dilatation Diseases 0.000 description 1
- 206010030194 Oesophageal stenosis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 1
- 229920003231 aliphatic polyamide Polymers 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 239000004760 aramid Substances 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010622 cold drawing Methods 0.000 description 1
- 230000008984 colonic lesion Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000002355 dual-layer Substances 0.000 description 1
- 238000012277 endoscopic treatment Methods 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1027—Making of balloon catheters
- A61M25/1029—Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
Definitions
- Balloons mounted on the distal ends of catheters are widely used in medical treatment.
- the balloon may be used to widen a vessel into which the catheter is inserted or to force open a blocked vessel.
- the requirements for strength and size of the balloons vary widely depending on the balloon's intended use and the vessel size into which the catheter is inserted.
- Perhaps the most demanding applications for such balloons are in balloon angioplasty in which catheters are inserted for long distances into extremely small vessels and used to open stenoses of blood vessels by balloon inflation. These applications require extremely thin walled, high strength, relatively inelastic balloons of predictable inflation properties.
- Thin walls are necessary because the balloon's wall and waist thicknesses limit the minimum diameter of the distal end of the catheter and therefore determine the limits on vessel size treatable by the method and the ease of passage of the catheter through the vascular system.
- High strength is necessary because when the balloon is used to push open a stenosis, the thin wall must not burst under the high internal pressures necessary to accomplish this task.
- the balloon must have some elasticity so that the inflated diameter can be controlled, enabling the surgeon to vary the balloon's diameter as required to treat individual lesions, but that elasticity must be relatively low so that the diameter is easily controllable. Small variations in pressure must not cause wide variation in diameter.
- Such angioplasty balloons have nominal diameters in the range of from about 1.25-4.5 mm.
- balloon dilatation is the most recently developed modality.
- Clinical research studies have been conducted to compare the efficacy of the technique to earlier approaches. For example, in one study evaluating Savary-Guillard ® Dilators versus balloon dilators for dilatation of benign esophageal strictures, both methods achieved effective dilatation. However, during the 24 month follow-up, 88% of patients treated with Savary dilators required redilations vs 54% of patients in the balloon group. As a result, the researchers concluded that, over the long term, the balloon may provide superior efficacy. Additional studies have clearly documented the convenience, effectiveness and safety of balloon dilatation of strictures.
- balloon dilatation over the alternative techniques is that it enables the clinician to dilate remote strictures throughout the GI tract.
- An example is the treatment of esophagal achalasia.
- the esophagus a hollow, muscular organ that originates at the pharynx and terminates at the stomach, functions to transport food and fluids from the pharynx to the stomach via a complex, neuromuscular response to the act of swallowing. Specifically, the passage of food or fluid from the pharynx into the esophagus stimulates the peristaltic contractions designed to propel the contents forward through the esophagus. Concurrently, the lower esophageal sphincter (LES) at the gastroesophagal junction relaxes allowing the passage of esophagal contents into the stomach.
- LES lower esophageal sphincter
- Achalasia is a disorder of unknown etiology that disrupts the normal esophageal function (3,4). In this disorder, two deficits are present. First, the normal esophagal peristaltic wave is absent. Second, the lower esophageal sphincter does not relax. The result is esophageal dilatation and severe, progressive dysphagia. Treatment for achalasia is aimed at reduction of LES pressure. This is accomplished nonsurgically via forceful balloon dilatation of the sphincter.
- Biliary dilatation may also be performed by such balloon catheter dilatation. Biliary strictures may result from variety of processes including postoperative scarring, inflammation, or malignancy. Endoscopic balloon dilatation of these lesions has been shown to be an effective treatment approach.
- the balloons for such devices desirably would have a long dilation length, high operating pressure, typically greater than 50 psi (3 atm, 344.7 kPa) and desirably up to 146 psi, (10 atm, 1013 kPa), low withdrawal force and high compliance.
- a compliance change is desirable which would allow a balloon having a 1.25-3.0 mm nominal diameter at 3 atm to grow in a generally linear manner at least 0.25 mm, preferably about 0.5 mm, or more as pressure is increased from 3 to 12 atm.
- a growth of at least 1.0 mm over the same range would be desirable.
- a growth of at least 2.0 mm over a 3-10 atm pressure range would be desirable.
- a compliance curve which provides growth of about 3 mm or more, preferably about 4.0 mm or more, over the range of 3 to 9 atm is desirable.
- a single layer angioplasty balloon made of a material such as PET which follows a stepped compliance curve.
- the stepped compliance curves of these balloons have a low pressure segment following a first generally linear profile, a transition region, typically in the 8-14 atm range, during which the balloon rapidly expands yielding inelastically, and a higher pressure region in which the balloon expands along a generally linear, low compliance curve.
- the stepped compliance curve allows a physician to dilate different sized lesions without using multiple balloon catheters.
- a polyethylene ionomer balloon with a stepped compliance curve is disclosed in EP 540 858.
- Block copolymer balloons for balloon catheters prepared using a particular heat set technique to stabilize the balloon dimensions, are also described in US 5,500,180.
- the invention provides balloons having the desired properties just described.
- the invention is a method for forming a balloon for a medical device in which a tubing of a thermoplastic polymer material is radially expanded under a first elevated pressure at a first elevated temperature to form the balloon at a first diameter, the thermoplastic polymer material being a block copolymer material and the method including the further step of annealing the balloon at a second elevated temperature less than or equal to the first temperature and a second pressure less than the first elevated pressure for a time sufficient to shrink the formed balloon to a second diameter less than the first diameter.
- the second temperature is in the range of 70-100°C
- the second pressure is no more than about 50 psi
- the time of annealing is sufficient to shrink the balloon so that its diameter at 3 atm pressure is about 90% or less, preferably about 85 % or less, of the 3 atm diameter of a correspondingly prepared balloon prepared without said shrinking step.
- the balloon may be shrunk at a very low inflation pressure (typically 0-10 psi) to a nominal diameter below that desired in the final balloon, and then pressurized at a pressure between the shrink pressure and 50 psi, at a temperature within the same range within a mold or cylinder which is sized to provide the desired nominal diameter, still below the diameter at which the balloon was initially blown, and suitably 90% or less of the initial blow diameter.
- a very low inflation pressure typically 0-10 psi
- the shrinking process used in the invention is quite different from the heat set technique used in US 5,500,180, in that the process of US 5,500,180, after formation of the balloon heats the balloon under pressure of 100-500 psi to a temperature above the blowing temperature specifically for the purpose of stabilizing the balloon against shrinkage upon cooling.
- the present invention is directed to exploitation of shrinkage behavior in order to increase the compliance of the resulting balloon.
- Balloons made of multiple layers of thermoplastic material such as coextruded balloons of the types described in US 5,195,969, US 5,270,086, and US 5,478,320, or separately blown dual layer balloons of the types described in US 5,512,051, WO 96/04951 and in copending application 08/611,644, filed 6 March 1996, all incorporated herein by reference, may also be employed in the present invention by shrinking the so-formed balloon in accordance with the present invention after it has been formed.
- balloons particularly suited to dilation of GI lesions of various types which are characterized by unique combinations of balloon diameter, high burst strength and high compliance characteristics.
- the high strength, high compliance balloons of the invention also provide excellent rewrap characteristics, in comparison to high strength balloons formed by other processes. Consequently, after treatment of a lesion and deflation of the balloon, the force required to withdraw the balloon catheter from the body is low, especially for catheters designed to pass through endoscopes (TTS).
- TTS endoscopes
- Fig. 1 is a schematic side view of a through-the scope dilatation catheter of the invention.
- Fig. 2 is a schematic side view of a dual lumen over-the wire dilatation catheter of the invention.
- Fig. 3 is a plot showing compliance curves of balloons prepared in Examples 3 and 4.
- Fig 4. is a plot showing compliance curves of balloons prepared in
- Example 5 is a plot showing compliance curves of balloons prepared in Example 6.
- balloon dilatation catheters for gastrointestinal applications are available in two design options: 1) through-the scope (TTS); and 2) over-the-wire (OTW).
- TTS through-the scope
- OGW over-the-wire
- a TTS balloon dilatation catheter 10 comprises a shaft 12, a balloon 14 near the distal end thereof and an inflation apparatus 16 at the proximal end thereof.
- Shaft 12 has a strong flexible kink-resistant construction and includes a longitudinal lumen extending therethrough by means of which the balloon 14 may be inflated by the inflation apparatus 16.
- Catheter 10 is designed for direct passage through the working channel of the endoscope to the site of an obstructive lesion. Because TTS catheters are not passed over a guidewire, the design includes a mechanism for stiffening the shaft enough to allow advancement through the narrow scope channel to the lesion. To achieve this result, TTS catheters suitably incorporate a stiffening stylet 18 within the shaft. This stylet extends from the proximal end of the shaft through the length of the balloon and provides the stiffness required to facilitate passage through an endoscope and enhance appropriate positioning within the lesion.
- TTS balloon dilatation catheters are useful when an endoscopist prefers to dilate under direct visualization.
- catheter advancement and balloon inflation can be directly monitored.
- Scope placement immediately proximal to the balloon also assists in maintaining proper balloon position during inflation.
- the balloon has a tendency to slip proximally or distally during inflation.
- the endoscopist is able to mechanically block any backward movement during inflation thereby facilitating efficient, effective dilatation.
- Fig. 2 illustrates the construction of an OTW balloon dilation catheter 30.
- Catheter 30 includes a shaft 32 which has a strong flexible kink-resistant construction and incorporates a double-lumen design. This design provides a lumen for guidewire passage and a lumen for balloon inflation. At the proximal end of catheter 30 the lumens of shaft 32 divide into separate portions 34, 36 which communicate respectively to balloon inflation apparatus 38 and to guidewire control apparatus 40. A balloon 42 is mounted on the shaft 32 near the distal end of catheter 30.
- Catheter 30 may incorporate a soft flexible tip 44 to provide less traumatic advancement through tortuous or narrow strictures. Tip 44 may be radiopaque to assist in fluoroscopic positioning of the catheter at the lesion site.
- OTW balloon dilatation catheters are the preferred design option when extremely tortuous of difficult anatomy is encountered. In these cases, the ability to track the catheter over a previously placed guidewire enhances the clinician's ability to precisely position the balloon for effective dilatation. Further, for colonic lesions distal to scope access, a fluoroscopically-guided, OTW placement technique can be used to achieve appropriate positioning. With OTW balloon dilatation catheters, the endoscopist typically monitors balloon inflation fluoroscopically rather than under direct visualization. Therefore, these dilators incorporate radiopaque markers to aid in accurate positioning. These catheters are designed to be used with guidewires and are available in a variety of shaft and balloon lengths and diameters. This allows the endoscopist to select a catheter appropriate for each lesion.
- the balloon must provide effective radial force against the entire length of the stricture.
- the balloon diameter is indicated by dimension A and the dilation length indicated by dimension B.
- the balloon should be long enough to dilate the entire length of the stricture.
- the inflated outer diameter should affect the desired degree of dilatation.
- the length of the catheter shaft required varies with the location of the stricture. For example, catheters 180 cm in length allow access to esophageal and pyloric lesions, while a catheter 240 cm in length is required for colonic strictures.
- Balloon Dilators which are inflated with air
- balloons are primarily inflated with water, saline or a contract/saline mixture.
- the latter is used with OTW balloon catheters to enhance visualization. It is important not to exceed the maximum inflation pressure specified for any particular balloon catheter. Surpassing this pressure could lead to balloon rupture.
- the balloon is fully inflated to the desired dilatation diameter. Dilatation force is applied for as long as necessary to achieve desired results.
- the balloons of the present invention provide a substantially wider range of stricture diameters which may be treated with a single catheter. After treatment, the deflated balloons of the invention provide substantially reduced resistance to withdrawal of the catheter from the body compared to prior art high strength balloons made for instance from biaxially oriented PET. In some TTS applications measured withdrawal force through the scope for catheters bearing balloons of the invention has been found to be only about 1/2 of the withdrawal force for corresponding catheters bearing PET balloons of similar burst strength.
- a balloon of approximately 8 cm length (dimension B), having an outer diameter (dimension A) of 6 to 20 mm is suitable.
- the preferred length of the catheter is 180 cm.
- a balloon of approximately 5.5 cm length balloon, having an outer diameter of 6 to 20 mm is suitable.
- the preferred length of the catheter is 180 cm.
- a balloon of approximately 5.5 cm length balloon, having an outer diameter of 6 to 20 mm is suitable.
- the preferred length of the catheter is 240 cm.
- a balloon of approximately 8 cm length balloon, having an outer diameter of 20-30 mm is suitable.
- the preferred length of the catheter is 240 cm.
- Preferred balloon materials are block copolymers or blends of flexible and rigid thermoplastic polymers.
- thermoplastic block copolymers characterized as follows: the block copolymer is made up of hard segments of a polyester or polyamide and soft segments of polyether; the polyester hard segments are polyesters of an aromatic dicarboxylic acid and a C 2 -C 4 diol, the polyamide hard segments are polyamides of C 6 or higher, preferably C 10 -C 12 , carboxylic acids and C 6 or higher, preferably C 10 - C 12 , organic diamines or of C 6 or higher, preferably C 10 -C ]2 , aliphatic ⁇ - amino- ⁇ -acids, and the polyether soft segments are polyethers of C 2 -C ] 0 , preferably
- the block copolymer has a low flexural modulus, namely less than 150,000 psi, preferably less than 120,000 psi, and has a hardness, Shore D scale, of greater than 60. From such polymers, balloons having very high compliance profiles can be prepared with high wall strength. The low flexural modulus contributes to a softer feel found with the balloons of the invention, compared to those made of other high strength polymer material.
- the preferred balloons of the invention are made of polyamide/polyether block copolymers.
- the polyamide/polyether block copolymers are commonly identified by the acronym PEBA (polyether block amide).
- PEBA polyether block amide
- the polyamide and polyether segments of these block copolymers may be linked through amide linkages, however, most preferred are ester linked segmented polymers, i.e. polyamide/polyether polyesters.
- Such polyamide/polyether/ polyester block copolymers are made by a molten state polycondensation reaction of a dicarboxylic polyamide and a polyether diol. The result is a short chain polyester made up of blocks of polyamide and polyether.
- the polyamide and polyether blocks are not miscible.
- the materials are characterized by a two phase structure: one is a thermoplastic region that is primarily polyamide and the other is elastomer region that is rich in polyether.
- the polyamide segments are semicrystalline at room temperature.
- the generalized chemical formula for these polyester polymers may be represented by the following formula:
- PA is a polyamide segment
- PE is a polyether segment
- the repeating number n is between 5 and 10.
- the polyamide segments are suitably aliphatic polyamides, such as nylons 12, 1 1, 9, 6, 6/12, 6/11, 6/9, or 616. Most preferably they are nylon 12 segments.
- the polyamide segments may also be based on aromatic polyamides but in such case significantly lower compliance characteristics are to be expected.
- the polyamide segments are relatively low molecular weight, generally within the range of 500-8,000, more preferably 2,000-6,000, most preferably about 3,000-5,000.
- the polyether segments are aliphatic polyethers having at least 2 and no more than 10 linear saturated aliphatic carbon atoms between ether linkages. More preferably the ether segments have 4-6 carbons between ether linkages, and most preferably they are poly(tetramethylene ether) segments. Examples of other polyethers which may be employed in place of the preferred tetramethylene ether segments include polyethylene glycol, polypropylene glycol, poly(pentamethylene ether) and poly(hexamethylene ether). The hydrocarbon portions of the polyether may be optionally branched. An example is the polyether of 2-ethylhexane diol. Generally such branches will contain no more than two carbon atoms.
- the molecular weight of the polyether segments is suitably between about 400 and 2,500, preferably between 650 and 1000.
- the weight ratio of polyamide to polyether in the polyamide/polyether polyesters used in the invention desirably should be in the range of 50/50 to 98/2, preferably between 60/30 and 92/08, more preferably, between 70/30 and 90/10.
- Polyamide/polyether polyesters are sold commercially under the Pebax ® trademark by Atochem North America, Inc., Philadelphia PA.
- suitable commercially available polymers are the Pebax® 33 series polymers with hardness 60 and above, Shore D scale, especially Pebax® 7233, 7033 and 6333. These polymers are made up of nylon 12 segments and poly (tetrame hylene ether) segments in different weight ratios and segment lengths.
- PEBA polymers with the physical properties specified herein and obtain similar compliance, strength and softness characteristics in the finished balloon.
- polyester/polyether segmented block copolymers are made up of at least two polyester and at least two polyether segments.
- the polyether segments are the same as previously described for the polyamide/polyether block copolymers useful in the invention.
- the polyester segments are polyesters of an aromatic dicarboxylic acid and a two to four carbon diol.
- Suitable dicarboxylic acids used to prepare the polyester segments of the polyester/polyether block copolymers are ortho-, meta- or para- phthalic acid, napthalenedicarboxylic acid or meta-terphenyl-4,4'-dicarboxylic acids.
- polyester/polyether block copolymers are poly(butylene terephthalate)- ⁇ /oc ⁇ -poIy(tetramethylene oxide) polymers such as Arnitel EM 740, sold by DSM Engineering Plastics. Hytrel polymers, sold by DuPont which meet the physical and chemical specifications set out herein can also be used.
- the block copolymers have a hardness, Shore D scale, of at least 60 and a flexural modulus of no more than about 150,000, in order to obtain optimal strength, compliance and softness characteristics.
- Shore D hardness is in the range of 65-75 and the flexural modulus is in the range of 50,000-
- the preferred polymers useful in the invention are also characterized by a high ultimate elongation of about 300% or higher and an ultimate tensile strength of at least 6,000 psi.
- thermoplastic polymer materials which may be used to prepare balloons in accordance with the invention include blends of rigid and flexible polymers; polyurethanes which have flexible portions, typically derived from polyester or polyether polyols and rigid portions, typically derived from diisocyanates; random copolymers of rigid and flexible monomers; aliphatic polyketones; polysulfides such as PPS (polyphenylenesulfide); polyamides, for instance C 6 or higher polyamides which are saturated with water, C ⁇ i or higher polyamide homopolymers regardless of water content, and polyamide copolymers of linear and branched monomer units; and other polymers or polymer blends which are known in the art as thermoplastic elastomers.
- thermoplastic polymer products which are considered suitable include polyurethane/polycarbonate blend or block copolymers sold under the trademarks, TEXIN TPU by Bayer Corp and TECOTHANE by Thermedics Inc. and polyurethanes sold under the trademark PELLETHANE by Dow Chemical Co.
- polyurethane/polycarbonate blend or block copolymers sold under the trademarks, TEXIN TPU by Bayer Corp and TECOTHANE by Thermedics Inc. and polyurethanes sold under the trademark PELLETHANE by Dow Chemical Co.
- multilayer balloon structures formed by concentric coextrusion of different thermoplastic polymers, or by sequential concentric blowing of separate tubing parisons of different materials may also be employed.
- Manufacture of balloons of the invention is started with an extruded tubing of the thermoplastic polymer material.
- the balloon prior to its being shrunk, may be manufactured in accordance with known techniques such as described in copending application 08/392,837, filed 2 March 1995, entitled Block Copolymer Elastomer Catheter Balloons, incorporated herein by reference, which corresponds to WO 95/23619, and Serial No. 08/555,219, filed 8 Nov. 1995, entitled Method of Balloon Formation by Cold Drawing/Necking, incorporated herein by reference. Multi-staged blowing techniques as described in copending application 08/197,639, filed 17 Feb. 1994, also incorporated herein by reference, may also be employed.
- the balloon shrinking process is similar to that described in US 5,348,538 for balloons of non-compliant material such as PET.
- the balloons of the invention are desirably constructed by blowing the balloon from a block copolymer or other polymer material as described above and then shrinking the balloon to a greater extent than was done in the specific illustrative examples of US 5,348,538.
- the amount of shrinkage is controlled by the pressure maintained in the balloon during annealing and the temperature and time of the annealing.
- the blowing pressure is suitably in the range 200-400 psi, and temperature is suitably in the range of 90-100°C, and the annealing pressure is in the range of 0-50, preferably 1-30 psi at 70-100°C for 3-30 seconds.
- the balloon may be shrunk at a very low inflation pressure (typically 0-30 psi) to a nominal diameter below that desired in the final balloon, and then pressurized at a pressure between the shrink pressure and 50 psi, at a temperature within the same range within a mold or cylinder which is sized to provide the desired nominal diameter, still below the diameter at which the balloon was initially blown, and suitably 90% or less of the initial blow diameter.
- a very low inflation pressure typically 0-30 psi
- Example 10 is illustrative of this technique.
- Example 1 (Comparative Example) Pebax ® 7233 tubes with dimensions of 0.105 inch ID (inner diameter) x 0.140 OD (outer diameter) are cold-drawn at a very low temperature, approximately in the range of -100°C to -20° C as follows.
- a screw driven stretching machine with a pair of pneumatic grippers is used to stretch the tubing.
- the center portion of the tube is cooled by directly spraying liquid N 2 on the center portion.
- Five 50 mm length balloons are blown at 95 °C in a 16 mm diameter mold using a blowing pressure of 260 psi and a tension of 160 grams.
- the average double wall thickness of the balloons was 0.00282 inch.
- the burst pressure was 9.2 atm.
- the compliance from 3 atm to 5 atm was 4.2% and from 3 atm to burst pressure was 11.7%.
- Example 2 Five balloons were prepared as in Example 1. The balloons, while inflated at about 5 psi pressure, were shrunk by dipping in a 80°C water bath for 5 minutes. The average double wall thickness after shrinking was 0.00429 inch. The average burst pressure of the balloons was 9.4 atm. The compliance from 3 atm to 5 atm was 15% and from 3 atm to burst pressure was 39%.
- Example 3 (Comparative Example) Pebax ® 7233 tubes with dimensions of 0.0264 inch ID x 0.0464 OD (outer diameter) are cold-drawn as in Example 1. A 4 mm balloon is blown at 95 °C in a mold using a blowing pressure of 450 psi and a tension of 300 grams. The burst pressure was 22 atm.
- Example 4
- Example 2 The process of Example 2 is repeated except that the shrinking step is performed by annealing the balloons while inflated to 2 atm pressure in water baths under different conditions, namely: 75 °C for 10 seconds; 75 °C for 30 seconds; 75 °C for 60 seconds; and 95 °C for 10 seconds. Compliance curves for the balloons of Examples 3 and 4 are plotted in Figure 3.
- Example 5 Balloons were prepared as in Examples 1 and 2 using Pebax 7033 polymer and the conditions specified in Table 1. The compliance results are summarized in Table 1 and are plotted in Figure 4.
- Example 6 Balloons were made from Arnitel EM 740 polymer tubing by stretching tubing as specified in Table 2 at room temperature at a stretch ratio of 4.2 and then blowing the balloon from the stretched tubing under the conditions specified in Table 2. The compliance results are summarized in Table 2 and are plotted in Figure 5.
- the balloons prepared utilizing the shrinking step have very high compliance profiles, in addition to high wall strength.
- the shrinking step causes the compliance curve to start from a lower point so that overall the balloon is much more compliant. In this manner the comparatively high strength of the block copolymer material is made accessible to medical device applications where high compliance is also desirable.
- Example 10 95 °C in an 8 mm diameter mold using a blowing pressure of 450 psi and a tension of 150 grams.
- the average double wall thickness of the balloons was 0.00174 inch.
- the average burst pressure was 13.6 atm.
- the compliance from 3 atm to 10 atm was 9.0%, and from 3 atm to burst pressure was 15%.
- Example 9 Five balloons were prepared as in Example 9. The balloons while at a tension and inflated at atmospheric pressure were shrunk by dipping in an 85° C water bath for 2 minutes. The balloons were then each inserted into a 5.6 mm ID glass tube, replaced in the 85° bath and pressurized at 30 psi for 2 minutes. The resulting balloons had an average double wall thickness of 0.00233 inch, an average burst pressure of 12.6 mm, a compliance from 3 atm to 10 atm of 36% and a compliance from 3 atm to burst of 44%.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Manufacturing & Machinery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP50455998A JP3597868B2 (ja) | 1996-07-23 | 1997-07-11 | 胃腸病巣処置に好適なカテーテル用高コンプライアンス高強度バルーン |
DE69727234T DE69727234T2 (de) | 1996-07-23 | 1997-07-11 | Verfahren zur herstellung von hochfesten dilatationsballons mit hoher compliance zur behandlung gastrointestinaler schädigungen |
CA002261217A CA2261217C (fr) | 1996-07-23 | 1997-07-11 | Catheter a ballonnet a coefficient d'elasticite et de resistance eleves utilisables dans le cadre du traitement de lesions gastro-intestinales |
AT97933387T ATE257721T1 (de) | 1996-07-23 | 1997-07-11 | Verfahren zur herstellung von hochfesten dilatationsballons mit hoher compliance zur behandlung gastrointestinaler schädigungen |
EP97933387A EP0921832B1 (fr) | 1996-07-23 | 1997-07-11 | Methode de fabrication de ballonnets de catheter a coefficients d'elasticite et de resistance eleves utilisables pour le traitement de lesions gastro-intestinales |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68533896A | 1996-07-23 | 1996-07-23 | |
US08/685,338 | 1996-07-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1998003218A1 true WO1998003218A1 (fr) | 1998-01-29 |
WO1998003218B1 WO1998003218B1 (fr) | 1998-03-12 |
WO1998003218A9 WO1998003218A9 (fr) | 1998-04-23 |
Family
ID=24751763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/012074 WO1998003218A1 (fr) | 1996-07-23 | 1997-07-11 | Catheter a ballonnet a coefficient d'elasticite et de resistance eleves utilisables dans le cadre du traitement de lesions gastro-intestinales |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0921832B1 (fr) |
JP (2) | JP3597868B2 (fr) |
AT (1) | ATE257721T1 (fr) |
CA (1) | CA2261217C (fr) |
DE (1) | DE69727234T2 (fr) |
WO (1) | WO1998003218A1 (fr) |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5868705A (en) * | 1996-05-20 | 1999-02-09 | Percusurge Inc | Pre-stretched catheter balloon |
JP2001029450A (ja) * | 1999-05-18 | 2001-02-06 | Kanegafuchi Chem Ind Co Ltd | 医療用ポリマーブレンド材料およびこの材料を用いた医療用バルーン |
US6319229B1 (en) | 1998-02-19 | 2001-11-20 | Medtronic Percusurge, Inc. | Balloon catheter and method of manufacture |
WO2002058913A1 (fr) * | 2001-01-24 | 2002-08-01 | Scimed Life Systems, Inc | Procede de fabrication de ballonnets de catheters par soufflage de preformes humides |
US6554795B2 (en) | 1997-03-06 | 2003-04-29 | Medtronic Ave, Inc. | Balloon catheter and method of manufacture |
US6607544B1 (en) | 1994-01-26 | 2003-08-19 | Kyphon Inc. | Expandable preformed structures for deployment in interior body regions |
US6719773B1 (en) | 1998-06-01 | 2004-04-13 | Kyphon Inc. | Expandable structures for deployment in interior body regions |
WO2004035128A1 (fr) * | 2002-10-15 | 2004-04-29 | Boston Scientific Limited | Ballonnet a deploiement controle |
WO2005061024A1 (fr) * | 2003-12-16 | 2005-07-07 | Advanced Cardiovascular Systems, Inc. | Revetements biologiquement absorbables a base de poly(ester amides) pour dispositifs implantables, et leurs procedes de fabrication |
WO2005089824A3 (fr) * | 2004-03-16 | 2005-11-17 | Advanced Cardiovascular System | Revetements biologiquement absorbables pour dispositifs implantables bases sur des copolymeres presentant des liaisons ester, et procedes de fabrication desdits revetements |
US7029732B2 (en) | 2002-02-28 | 2006-04-18 | Boston Scientific Scimed, Inc. | Medical device balloons with improved strength properties and processes for producing same |
US7166680B2 (en) | 2004-10-06 | 2007-01-23 | Advanced Cardiovascular Systems, Inc. | Blends of poly(ester amide) polymers |
US7261720B2 (en) | 2002-01-11 | 2007-08-28 | Kyphon Inc. | Inflatable device for use in surgical protocol relating to fixation of bone |
US7435788B2 (en) | 2003-12-19 | 2008-10-14 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US7572287B2 (en) | 2001-10-25 | 2009-08-11 | Boston Scientific Scimed, Inc. | Balloon expandable polymer stent with reduced elastic recoil |
US7635510B2 (en) | 2004-07-07 | 2009-12-22 | Boston Scientific Scimed, Inc. | High performance balloon catheter/component |
WO2009155045A1 (fr) | 2008-06-18 | 2009-12-23 | Boston Scientific Scimed, Inc. | Nouveau ballonnet fonctionnel avec système de lubrification ou d’administration de médicament intégrés |
AU2003272000B2 (en) * | 2003-10-17 | 2010-04-29 | Invatec S.R.L. | Catheter balloons |
US7727442B2 (en) | 2003-07-10 | 2010-06-01 | Boston Scientific Scimed, Inc. | Medical device tubing with discrete orientation regions |
US7892478B2 (en) | 2004-04-19 | 2011-02-22 | Boston Scientific Scimed, Inc. | Catheter balloon mold form and molding process |
US7892469B2 (en) * | 1998-04-21 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Method of making a non-compliant balloon for a catheter |
US7943221B2 (en) | 2006-05-22 | 2011-05-17 | Boston Scientific Scimed, Inc. | Hinged compliance fiber braid balloon |
US8349237B2 (en) | 2006-04-20 | 2013-01-08 | Boston Scientific Scimed, Inc. | High pressure balloon |
US20170233520A1 (en) * | 2014-03-25 | 2017-08-17 | Basf Se | Tpu pneumatic hose |
US10849629B2 (en) | 2016-12-13 | 2020-12-01 | Boston Scientific Scimed, Inc. | Medical balloon |
US10987496B2 (en) | 2017-04-25 | 2021-04-27 | Boston Scientific Scimed, Inc. | Medical balloon |
US20210361918A1 (en) * | 2019-02-22 | 2021-11-25 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11191930B2 (en) | 2016-04-12 | 2021-12-07 | Boston Scientific Scimed, Inc. | Medical balloon |
CN114177489A (zh) * | 2021-12-17 | 2022-03-15 | 普利瑞医疗科技(苏州)有限公司 | 一种鼓泡球囊的制备方法 |
US11730864B2 (en) | 2015-04-24 | 2023-08-22 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US11826532B2 (en) | 2012-10-26 | 2023-11-28 | Urotronic, Inc. | Balloon catheters for body lumens |
US11925729B2 (en) | 2012-10-26 | 2024-03-12 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11938287B2 (en) | 2012-10-26 | 2024-03-26 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US12115286B2 (en) | 2012-10-26 | 2024-10-15 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US12280226B2 (en) | 2012-10-26 | 2025-04-22 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US12296120B2 (en) | 2021-11-02 | 2025-05-13 | Boston Scientific Scimed, Inc. | Medical balloon |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7005097B2 (en) * | 2002-01-23 | 2006-02-28 | Boston Scientific Scimed, Inc. | Medical devices employing chain extended polymers |
JP4967258B2 (ja) * | 2004-06-10 | 2012-07-04 | 株式会社カネカ | バルーンおよびバルーンカテーテル |
WO2006126311A1 (fr) * | 2005-05-27 | 2006-11-30 | Kaneka Corporation | Ballon et cathéter à ballon |
JP2007061258A (ja) * | 2005-08-30 | 2007-03-15 | Kaneka Corp | バルーンおよびバルーンカテーテル |
JP2015104485A (ja) | 2013-11-29 | 2015-06-08 | オリンパスメディカルシステムズ株式会社 | カテーテル |
WO2015175252A1 (fr) * | 2014-05-16 | 2015-11-19 | Boston Scientific Scimed, Inc. | Cathéter à ballonnet multicouche à faible coût à haute pression |
PL3664706T3 (pl) * | 2017-08-10 | 2022-02-14 | Vipun Medical Nv | Urządzenie do pomiaru zmian ciśnienia w żołądku |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0439202A2 (fr) * | 1989-07-24 | 1991-07-31 | Cordis Corporation | Appareil et procédé pour la fabrication de ballons pour dispositifs médicaux |
EP0485903A2 (fr) * | 1990-11-10 | 1992-05-20 | Terumo Kabushiki Kaisha | Ballon pour cathéter, cathéter à ballonnet équipé avec le ballon et procédé de sa fabrication |
US5195969A (en) | 1991-04-26 | 1993-03-23 | Boston Scientific Corporation | Co-extruded medical balloons and catheter using such balloons |
EP0540858A1 (fr) | 1991-09-12 | 1993-05-12 | Advanced Cardiovascular Systems, Inc. | Objet gonflable ayant une expansion élastique limitée |
US5270086A (en) | 1989-09-25 | 1993-12-14 | Schneider (Usa) Inc. | Multilayer extrusion of angioplasty balloons |
EP0592885A2 (fr) * | 1992-09-30 | 1994-04-20 | C.R. Bard, Inc. | Ballon de dilatation gonflable réagissant aux tensions élastiques, et sa fabrication |
US5348538A (en) | 1992-09-29 | 1994-09-20 | Scimed Life Systems, Inc. | Shrinking balloon catheter having nonlinear or hybrid compliance curve |
WO1995023619A1 (fr) | 1994-03-02 | 1995-09-08 | Scimed Life Systems, Inc. | Ballonnets de catheter en elastomere de copolymere bloc |
US5478320A (en) | 1989-11-29 | 1995-12-26 | Cordis Corporation | Puncture resistant balloon catheter and method of manufacturing |
WO1996004951A1 (fr) | 1994-08-15 | 1996-02-22 | Schneider (Usa) Inc. | Procede de fabrication sans co-extrusion de ballonnets d'angioplastie a couches multiples |
US5512051A (en) | 1993-02-16 | 1996-04-30 | Boston Scientific Corporation | Slip-layered catheter balloon |
WO1996012516A1 (fr) * | 1994-10-19 | 1996-05-02 | Advanced Cardiovascular Systems, Inc. | Ballonnets de dilatation tres resistant |
-
1997
- 1997-07-11 WO PCT/US1997/012074 patent/WO1998003218A1/fr active IP Right Grant
- 1997-07-11 DE DE69727234T patent/DE69727234T2/de not_active Expired - Lifetime
- 1997-07-11 AT AT97933387T patent/ATE257721T1/de not_active IP Right Cessation
- 1997-07-11 JP JP50455998A patent/JP3597868B2/ja not_active Expired - Lifetime
- 1997-07-11 EP EP97933387A patent/EP0921832B1/fr not_active Expired - Lifetime
- 1997-07-11 CA CA002261217A patent/CA2261217C/fr not_active Expired - Fee Related
-
2004
- 2004-04-21 JP JP2004125008A patent/JP4643173B2/ja not_active Expired - Lifetime
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0439202A2 (fr) * | 1989-07-24 | 1991-07-31 | Cordis Corporation | Appareil et procédé pour la fabrication de ballons pour dispositifs médicaux |
US5270086A (en) | 1989-09-25 | 1993-12-14 | Schneider (Usa) Inc. | Multilayer extrusion of angioplasty balloons |
US5478320A (en) | 1989-11-29 | 1995-12-26 | Cordis Corporation | Puncture resistant balloon catheter and method of manufacturing |
EP0485903A2 (fr) * | 1990-11-10 | 1992-05-20 | Terumo Kabushiki Kaisha | Ballon pour cathéter, cathéter à ballonnet équipé avec le ballon et procédé de sa fabrication |
US5195969A (en) | 1991-04-26 | 1993-03-23 | Boston Scientific Corporation | Co-extruded medical balloons and catheter using such balloons |
EP0540858A1 (fr) | 1991-09-12 | 1993-05-12 | Advanced Cardiovascular Systems, Inc. | Objet gonflable ayant une expansion élastique limitée |
US5348538A (en) | 1992-09-29 | 1994-09-20 | Scimed Life Systems, Inc. | Shrinking balloon catheter having nonlinear or hybrid compliance curve |
EP0592885A2 (fr) * | 1992-09-30 | 1994-04-20 | C.R. Bard, Inc. | Ballon de dilatation gonflable réagissant aux tensions élastiques, et sa fabrication |
US5500180A (en) | 1992-09-30 | 1996-03-19 | C. R. Bard, Inc. | Method of making a distensible dilatation balloon using a block copolymer |
US5512051A (en) | 1993-02-16 | 1996-04-30 | Boston Scientific Corporation | Slip-layered catheter balloon |
WO1995023619A1 (fr) | 1994-03-02 | 1995-09-08 | Scimed Life Systems, Inc. | Ballonnets de catheter en elastomere de copolymere bloc |
WO1996004951A1 (fr) | 1994-08-15 | 1996-02-22 | Schneider (Usa) Inc. | Procede de fabrication sans co-extrusion de ballonnets d'angioplastie a couches multiples |
WO1996012516A1 (fr) * | 1994-10-19 | 1996-05-02 | Advanced Cardiovascular Systems, Inc. | Ballonnets de dilatation tres resistant |
Cited By (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6979341B2 (en) | 1994-01-26 | 2005-12-27 | Kyphon Inc. | Expandable preformed structures for deployment in interior body regions |
US6607544B1 (en) | 1994-01-26 | 2003-08-19 | Kyphon Inc. | Expandable preformed structures for deployment in interior body regions |
US5868705A (en) * | 1996-05-20 | 1999-02-09 | Percusurge Inc | Pre-stretched catheter balloon |
US6554795B2 (en) | 1997-03-06 | 2003-04-29 | Medtronic Ave, Inc. | Balloon catheter and method of manufacture |
US6319229B1 (en) | 1998-02-19 | 2001-11-20 | Medtronic Percusurge, Inc. | Balloon catheter and method of manufacture |
US7892469B2 (en) * | 1998-04-21 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Method of making a non-compliant balloon for a catheter |
US7722624B2 (en) | 1998-06-01 | 2010-05-25 | Kyphon SÀRL | Expandable structures for deployment in interior body regions |
US7875035B2 (en) | 1998-06-01 | 2011-01-25 | Kyphon Sarl | Expandable structures for deployment in interior body regions |
US6719773B1 (en) | 1998-06-01 | 2004-04-13 | Kyphon Inc. | Expandable structures for deployment in interior body regions |
JP2001029450A (ja) * | 1999-05-18 | 2001-02-06 | Kanegafuchi Chem Ind Co Ltd | 医療用ポリマーブレンド材料およびこの材料を用いた医療用バルーン |
WO2002058913A1 (fr) * | 2001-01-24 | 2002-08-01 | Scimed Life Systems, Inc | Procede de fabrication de ballonnets de catheters par soufflage de preformes humides |
US7572287B2 (en) | 2001-10-25 | 2009-08-11 | Boston Scientific Scimed, Inc. | Balloon expandable polymer stent with reduced elastic recoil |
US7261720B2 (en) | 2002-01-11 | 2007-08-28 | Kyphon Inc. | Inflatable device for use in surgical protocol relating to fixation of bone |
US9801981B2 (en) | 2002-02-28 | 2017-10-31 | Boston Scientific Scimed, Inc. | Medical device balloons with improved strength properties and processes for producing the same |
US7029732B2 (en) | 2002-02-28 | 2006-04-18 | Boston Scientific Scimed, Inc. | Medical device balloons with improved strength properties and processes for producing same |
US9956321B2 (en) | 2002-02-28 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical device balloons with improved strength properties and processes for producing same |
WO2004035128A1 (fr) * | 2002-10-15 | 2004-04-29 | Boston Scientific Limited | Ballonnet a deploiement controle |
US6835189B2 (en) | 2002-10-15 | 2004-12-28 | Scimed Life Systems, Inc. | Controlled deployment balloon |
US8304050B2 (en) | 2003-07-10 | 2012-11-06 | Boston Scientific Scimed, Inc. | Medical device tubing with discrete orientation regions |
US7727442B2 (en) | 2003-07-10 | 2010-06-01 | Boston Scientific Scimed, Inc. | Medical device tubing with discrete orientation regions |
US8268418B2 (en) | 2003-10-17 | 2012-09-18 | Medtronic, Inc. | Catheter balloons |
AU2003272000B2 (en) * | 2003-10-17 | 2010-04-29 | Invatec S.R.L. | Catheter balloons |
EP1952830A1 (fr) * | 2003-12-16 | 2008-08-06 | Abbott Cardiovascular Systems, Inc. | Revêtements biologiquement absorbables pour dispositifs implantables basées sur des poly(ester amides) et leurs procédés de fabrication |
US7220816B2 (en) | 2003-12-16 | 2007-05-22 | Advanced Cardiovascular Systems, Inc. | Biologically absorbable coatings for implantable devices based on poly(ester amides) and methods for fabricating the same |
WO2005061024A1 (fr) * | 2003-12-16 | 2005-07-07 | Advanced Cardiovascular Systems, Inc. | Revetements biologiquement absorbables a base de poly(ester amides) pour dispositifs implantables, et leurs procedes de fabrication |
US7435788B2 (en) | 2003-12-19 | 2008-10-14 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US7632914B2 (en) | 2003-12-19 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
WO2005089824A3 (fr) * | 2004-03-16 | 2005-11-17 | Advanced Cardiovascular System | Revetements biologiquement absorbables pour dispositifs implantables bases sur des copolymeres presentant des liaisons ester, et procedes de fabrication desdits revetements |
US8062024B2 (en) | 2004-04-19 | 2011-11-22 | Boston Scientific Scimed, Inc. | Catheter balloon mold form and molding process |
US7892478B2 (en) | 2004-04-19 | 2011-02-22 | Boston Scientific Scimed, Inc. | Catheter balloon mold form and molding process |
US7635510B2 (en) | 2004-07-07 | 2009-12-22 | Boston Scientific Scimed, Inc. | High performance balloon catheter/component |
US8481139B2 (en) | 2004-07-07 | 2013-07-09 | Boston Scientific Scimed, Inc. | High performance balloon catheter/component |
US7520891B2 (en) | 2004-10-06 | 2009-04-21 | Advanced Cardiovascular Systems, Inc. | Blends of poly(ester amide) polymers |
US7507251B2 (en) | 2004-10-06 | 2009-03-24 | Advanced Cardiovascular Systems, Inc. | Blends of poly(ester amide) polymers |
US7365133B2 (en) | 2004-10-06 | 2008-04-29 | Advanced Cardiovascular Systems, Inc. | Blends of poly(ester amide) polymers |
US7166680B2 (en) | 2004-10-06 | 2007-01-23 | Advanced Cardiovascular Systems, Inc. | Blends of poly(ester amide) polymers |
US10675449B2 (en) | 2006-04-20 | 2020-06-09 | Boston Scientific Scimed, Inc. | High pressure balloon |
US8349237B2 (en) | 2006-04-20 | 2013-01-08 | Boston Scientific Scimed, Inc. | High pressure balloon |
US8697212B2 (en) | 2006-04-20 | 2014-04-15 | Boston Scientific Scimed, Inc. | High pressure balloon |
US8858855B2 (en) | 2006-04-20 | 2014-10-14 | Boston Scientific Scimed, Inc. | High pressure balloon |
US9144666B2 (en) | 2006-04-20 | 2015-09-29 | Boston Scientific Scimed, Inc. | High pressure balloon |
US9526873B2 (en) | 2006-04-20 | 2016-12-27 | Boston Scientific Scimed, Inc. | High pressure balloon |
US10099039B2 (en) | 2006-04-20 | 2018-10-16 | Boston Scientific Scimed, Inc. | High pressure balloon |
US7943221B2 (en) | 2006-05-22 | 2011-05-17 | Boston Scientific Scimed, Inc. | Hinged compliance fiber braid balloon |
WO2009155045A1 (fr) | 2008-06-18 | 2009-12-23 | Boston Scientific Scimed, Inc. | Nouveau ballonnet fonctionnel avec système de lubrification ou d’administration de médicament intégrés |
US11938287B2 (en) | 2012-10-26 | 2024-03-26 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11925729B2 (en) | 2012-10-26 | 2024-03-12 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US12168108B2 (en) | 2012-10-26 | 2024-12-17 | Urotronic, Inc. | Balloon catheters for body lumens |
US12280226B2 (en) | 2012-10-26 | 2025-04-22 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US12115286B2 (en) | 2012-10-26 | 2024-10-15 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US12280179B2 (en) | 2012-10-26 | 2025-04-22 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11826533B2 (en) | 2012-10-26 | 2023-11-28 | Urotronic, Inc. | Balloon catheters for body lumens |
US11826532B2 (en) | 2012-10-26 | 2023-11-28 | Urotronic, Inc. | Balloon catheters for body lumens |
US20170233520A1 (en) * | 2014-03-25 | 2017-08-17 | Basf Se | Tpu pneumatic hose |
US11730864B2 (en) | 2015-04-24 | 2023-08-22 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US11904072B2 (en) | 2015-04-24 | 2024-02-20 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US12102737B2 (en) | 2015-04-24 | 2024-10-01 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US11191930B2 (en) | 2016-04-12 | 2021-12-07 | Boston Scientific Scimed, Inc. | Medical balloon |
US10849629B2 (en) | 2016-12-13 | 2020-12-01 | Boston Scientific Scimed, Inc. | Medical balloon |
US10987496B2 (en) | 2017-04-25 | 2021-04-27 | Boston Scientific Scimed, Inc. | Medical balloon |
US12005206B2 (en) | 2019-02-22 | 2024-06-11 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11957853B2 (en) * | 2019-02-22 | 2024-04-16 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US20210361918A1 (en) * | 2019-02-22 | 2021-11-25 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US12296120B2 (en) | 2021-11-02 | 2025-05-13 | Boston Scientific Scimed, Inc. | Medical balloon |
CN114177489A (zh) * | 2021-12-17 | 2022-03-15 | 普利瑞医疗科技(苏州)有限公司 | 一种鼓泡球囊的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
EP0921832B1 (fr) | 2004-01-14 |
EP0921832A1 (fr) | 1999-06-16 |
DE69727234T2 (de) | 2004-11-11 |
CA2261217C (fr) | 2008-07-08 |
JP3597868B2 (ja) | 2004-12-08 |
DE69727234D1 (de) | 2004-02-19 |
ATE257721T1 (de) | 2004-01-15 |
JP2000515036A (ja) | 2000-11-14 |
JP4643173B2 (ja) | 2011-03-02 |
JP2004223280A (ja) | 2004-08-12 |
CA2261217A1 (fr) | 1998-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0921832B1 (fr) | Methode de fabrication de ballonnets de catheter a coefficients d'elasticite et de resistance eleves utilisables pour le traitement de lesions gastro-intestinales | |
US20070009692A1 (en) | High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions | |
WO1998003218A9 (fr) | Catheter a ballonnet a coefficient d'elasticite et de resistance eleves utilisables dans le cadre du traitement de lesions gastro-intestinales | |
US11357892B2 (en) | Multilayer medical balloon | |
US20020018866A1 (en) | Polyether block amide catheter balloons | |
US6124007A (en) | Laminate catheter balloons with additive burst strength and methods for preparation of same | |
US9669196B2 (en) | Robust multi-layer balloon | |
EP2361103B1 (fr) | Tube de cathéter à faible élasticité | |
US20090264822A1 (en) | Method of Making a Zero-Fold Balloon With Variable Inflation Volume | |
US20090254113A1 (en) | Dilatation balloon with ridges and methods | |
JP4815657B2 (ja) | 医療用ポリマーブレンド材料およびこの材料を用いた医療用バルーン | |
JP4402218B2 (ja) | バルーンカテーテル |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
COP | Corrected version of pamphlet |
Free format text: PAGE 1, DESCRIPTION, AND PAGES 1/4-4/4, DRAWINGS, REPLACED BY NEW PAGES BEARING THE SAME NUMBER; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2261217 Country of ref document: CA Ref country code: CA Ref document number: 2261217 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997933387 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997933387 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1997933387 Country of ref document: EP |